Grünenthal Headquarter

Our Corporate Responsibility Programme

Corporate responsibility is at the core of our business strategy and culture. It runs through everything we do. We want to create a net positive impact for patients, employees, partners and wider society, and work towards reducing our impact on the environment. To make this happen, we have established impact initiatives with ambitious goals. Our performance is regularly rated by an independent agency according to environmental, social and governance (ESG) criteria.

The different modules of our Corporate Responsibility Programme

Diagram: The four modules of our Corporate Responsibility Programme
To make sure that we create a positive impact in everything we do, our Corporate Responsibility Programme is built on four modules: Fields of Action, Ethical Framework, ESG Risk Management and Corporate Governance. We ensure maximum positive impact through our four fields of action. Our stringent ethical framework guides us how we work. An independent agency regularly monitors and assesses our environmental, social and governance risk. Our corporate governance system ensures that we constantly live our values.

Our Fields of Action – for maximum positive impact

Our Fields of Action – for maximum positive impact

Our four fields of action make sure that we create maximum positive impact. For each field, we have identified material – or relevant and essential – topics with specific ambitions and KPIs. You can find details about these measures on the respective subpages.


Compliance, Ethics and Transparency

Maintaining excellence in the areas of compliance, ethics and transparency is at the core of our daily work. We aim to operate our business with the highest ethical standards, and we strive for continuous improvement.

... Read more

Our Impact Initiatives

The ambitious goals, structured in our five impact initiatives, are built in a way to optimise the positive impact for the people we work with, the patients we serve and to reduce our impact on the environment. These include:


Doctor patients conversation
Female Grünenthal Lab Employee
Female Doctor in an online appointment with a patient
Impact initiative “Education of Patients & Healthcare Professionals”

– educating healthcare professionals on the responsible use of pain medicines and thereby supporting patients on their journey to achieving optimal pain management.

Impact initiative “Data-driven Human Disease Understanding”

– building our understanding of human disease to enhance our ability to create truly novel medicines for patients in need.

Impact initiative “Global Grünenthal Platform for Awareness & Access”

– establishing one joint platform to ensure access to medicine and raise awareness about pain and palliative care; thereby improving accessibility for patients to adequate pain treatment, particularly among underserved populations.



Happy female Grünenthal Employees
Hand holding a crystal ball which reflects a Grünenthal building from our Campus in Aachen, Germany
Impact initiative “Circle of Trust”

– establishing a “Diversity & Engagement Council” to foster a culture of trust among employees, partners and the community.

Impact initiative “Driving Environmental Sustainability”

– using resources sustainably, avoiding waste in our operations, working with our suppliers to reduce environmental impacts and working towards powering our sites with low carbon or renewable energy sources.

Logo Sustainalytics a Morningstar company rated

Our ESG Risk Rating

Our performance in environmental, social and governance (ESG) criteria is reflected in an external rating by Sustainalytics. We were attributed a medium ESG risk. This places Grünenthal in the top three percent of the global pharmaceuticals subindustry that inherently features higher ESG risk.

... Read more